Sign in

CIK 0001412408

  • Large accelerated filer

Phreesia, Inc.

Sign in to watch
Ticker
PHR
Exchange
NYSE
Industry
Services-Business Services, NEC
FY end
Jan 31
Incorporated
DE
Entity type
Operating
Phone
+1 888-654-7473
Business address
1521 CONCORD PIKE, SUITE 301 PMB 221, WILMINGTON, DE, 19803
Former names
Phreesia Inc
Open-market buys, last 90 days
$683
in 1 filing
Open-market sales, last 90 days
$67,153
in 1 filing, $67K under 10b5-1 plans

Net −$66,470. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-03-26 Gandhi Balaji Chief Financial Officer Sale −1,827 $27.46 $50K 103,591
2025-03-19 Linetsky David SVP, Life Sciences Sale −81 $27.85 $2K 8,731
2025-03-19 Linetsky David SVP, Life Sciences Sale −7 $28.31 $198 8,724
2025-03-18 Linetsky David SVP, Life Sciences Sale −39 $26.95 $1K 8,812
2025-03-17 Hoffman Allison C General Counsel & Secretary Sale 10b5-1 −3,496 $25.32 $89K 139,134
2025-02-19 Roberts Evan Chief Operating Officer Sale 10b5-1 −177 $30.00 $5K 741,020
2025-02-19 Gandhi Balaji Chief Financial Officer Sale 10b5-1 −96 $30.00 $3K 105,418
2025-02-18 Roberts Evan Chief Operating Officer Sale 10b5-1 −3,519 $30.06 $106K 741,197
2025-02-18 Gandhi Balaji Chief Financial Officer Sale 10b5-1 −5,771 $30.04 $173K 105,514
2025-02-18 Hoffman Allison C General Counsel & Secretary Sale 10b5-1 −3,496 $29.72 $104K 142,630
2025-02-14 Roberts Evan Chief Operating Officer Sale 10b5-1 −3,586 $30.13 $108K 744,716
2025-02-14 Gandhi Balaji Chief Financial Officer Sale 10b5-1 −4,889 $30.09 $147K 111,285
2025-02-13 Roberts Evan Chief Operating Officer Sale 10b5-1 −16,005 $30.00 $480K 748,302
2025-02-13 Gandhi Balaji Chief Financial Officer Sale 10b5-1 −28,759 $30.00 $863K 116,174
2025-02-13 Linetsky David SVP, Life Sciences Sale 10b5-1 −11,616 $29.70 $345K 218,135
2025-02-07 Linetsky David SVP, Life Sciences Sale 10b5-1 −300 $29.52 $9K 229,751
2025-02-05 Linetsky David SVP, Life Sciences Sale 10b5-1 −720 $29.50 $21K 230,051
2025-01-31 Munson Gillian Director Grant or award +351 $28.46 $10K 37,074
2023-12-18 Linetsky David SVP, Life Sciences Sale −100 $23.15 $2K 9,904
2022-12-15 Linetsky David SVP, Life Sciences Sale −22 $34.01 $748 9,770

Page 14 of 15 · 283 trades